<?xml version="1.0" encoding="UTF-8"?>
<p>4-(4-(1-Methyl-1H-indol-3-yl)butanamido)-N-hydroxybenzamide (
 <bold>I13</bold>). HRMS (AP-ESI) 
 <italic>m/z</italic> calcd for C
 <sub>20</sub>H
 <sub>21</sub>N
 <sub>3</sub>O
 <sub>3</sub> [M + H]
 <sup>+</sup> 352.16165, found 352.16403. 
 <sup>1</sup>H NMR (400 MHz, DMSO) 
 <italic>δ</italic> 11.09 (s, 1H), 10.11 (s, 1H), 8.93 (s, 1H), 7.68 (dd, 
 <italic>J</italic> = 18.4, 8.8 Hz, 4H), 7.54 (d, 
 <italic>J</italic> = 7.8 Hz, 1H), 7.37 (d, 
 <italic>J</italic> = 8.2 Hz, 1H), 7.15–7.12 (m, 2H), 7.03–6.99 (m, 1H), 3.73 (s, 3H), 2.73 (t, 
 <italic>J</italic> = 7.4 Hz, 2H), 2.40 (t, 
 <italic>J</italic> = 7.3 Hz, 2H), 2.01–1.93 (m, 2H); 
 <sup>13</sup>C NMR (400 MHz, DMSO): 
 <italic>δ</italic> = 172.04, 164.41, 142.34, 137.15, 128.11, 127.94, 127.37, 127.31, 121.46, 119.02, 118.72, 118.70, 113.75, 110.00, 36.61, 32.67, 26.26, 24.56 ppm.
</p>
